Abstraction Health

Quercetin

Flavonoid

Also known as: Quercetin dihydrate · Quercetin phytosome

🟠Weak Evidence 92 expert mentions 20 studies
C·62/100·Fair
Research Depth25/25
Study Quality11/25
Expert Consensus19/25
Claim Support7/25
How we score the evidence →

A plant flavonoid with anti-inflammatory, antioxidant, and senolytic properties. Studied for immune function, cardiovascular health, and as part of senolytic protocols (with dasatinib). Poor bioavailability requires enhanced formulations.

Common forms:standard powderquercetin phytosomewith bromelain

How expert claims hold up

79 of 92 claims assessed
15Supported7Partial57Insufficient13Pending

22 of 79 assessed claims supported or partially supported by published research

Expert Consensus

Universal consensusResearch agrees
2/5
Experts mention
2
Recommend
0
Flag caution
Rhonda Patrick
Rhonda Patrick Recommends
Research agrees79 claims250-500milligrams or 500milligramsbioavailable formulationphytosomestandard form
David Sinclair
David Sinclair Recommends
Pending review13 claims

Dose divergence: Experts recommend different amounts (250-500milligrams, 500milligrams). Check the Stack & Timing tab for study-backed dosing ranges.

Evidence Summary

PubMed / NCBI·May 2026
All 21 studies
21
Studies
1
RCTs
17
Reviews

Quercetin is a naturally occurring flavonoid polyphenol found in common foods such as onions, capers, apples, and kale, and has been the subject of scientific investigation for several decades. The available literature — consisting primarily of reviews and systematic reviews, with a small number of meta-analyses — suggests quercetin has broad biological activity, including antioxidant, anti-inflammatory, anti-allergic, and potentially cardioprotective properties. However, the majority of expert claims about quercetin's specific health benefits were rated as having insufficient evidence, meaning the research base, while active, has not yet produced consistent, high-quality human trial data to firmly support many of the therapeutic applications being discussed. Across the 15 available publications, the strongest evidence comes from meta-analyses examining quercetin's effects on blood pressure and its bioavailability in humans, as well as systematic reviews on bone metabolism and cardiovascular risk reduction. These higher-quality studies suggest quercetin supplementation may modestly influence blood pressure and that its bioavailability varies considerably depending on the delivery format. Systematic reviews also touch on quercetin's potential roles in rheumatoid arthritis disease activity and bone health, though findings across these areas are not consistently robust. Reviews covering inflammation, allergy, exercise-induced muscle damage, Alzheimer's prevention, diabetes management, and anti-aging applications exist but are largely narrative in nature and do not provide the same level of evidential weight. A major limitation across this evidence base is that the majority of publications are reviews rather than original clinical trials — and even the systematic reviews frequently draw on studies with small sample sizes, heterogeneous populations, and variable dosing protocols. Crucially, none of the listed studies report specific participant populations or sample sizes, which makes it difficult to assess how broadly any findings apply. More than 70% of the expert claims analyzed were classified as having insufficient evidence, underscoring that quercetin remains a supplement with considerable theoretical and preclinical support but limited definitive human trial data. Key unknowns include optimal dosing, long-term safety at supplemental doses, and whether benefits observed in controlled settings translate to real-world outcomes.

Read full evidence summary →

Top studies

The Effects of Quercetin Supplementation on Blood Pressure - Meta-Analysis.

Current problems in cardiology · 2022 · Popiolek-Kalisz J et al.
Meta-Analysis🟢
Key finding

The Effects of Quercetin Supplementation on Blood Pressure - Meta-Analysis.

PMID: 35948195DOI: 10.1016/j.cpcardiol.2022.101350
View on PubMed

Improving quercetin bioavailability: A systematic review and meta-analysis of human intervention studies.

Food chemistry · 2025 · Liu L et al.
Meta-Analysis🟢
Key finding

Improving quercetin bioavailability: A systematic review and meta-analysis of human intervention studies.

COI: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Gary Williamson reports a relationship with Access Business Group LLC West Coast Office that includes: consulting or advisory and funding grants. Gary Williamson reports a relationship with The Product Makers, Australia that includes: funding grants. Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PMID: 40037045DOI: 10.1016/j.foodchem.2025.143630
View on PubMed

Expert Mentions

All 92 mentions
Rhonda Patrick
Rhonda Patrick
FoundMyFitness
Direct recommendation

For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.

Extracted claim

For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.

250-500 milligramsbioavailable formulationdaily📍 anti-inflammatory and antioxidant support
Insufficient evidence to assessHigh confidence

None of the 10 retrieved studies provide extractable key findings, populations, or limitations, making it impossible to directly evaluate the specific dose range of 250–500 mg of a bioavailable querce…

Rhonda Patrick
Rhonda Patrick
FoundMyFitness
Direct recommendation

For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.

Extracted claim

For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.

250-500 milligramsbioavailable formulationdaily📍 anti-inflammatory and antioxidant support
Insufficient evidence to assessHigh confidence

None of the 10 retrieved studies provide extractable key findings, population data, or dose-specific details that directly evaluate the 250–500 mg quercetin range for daily anti-inflammatory or antiox…

Safety, interactions & who should avoid Quercetin

generally_recognized_safe

A dedicated review on the safety of quercetin as a dietary supplement suggests it is generally well-tolerated at typical supplemental doses, with no major adverse effects reported in short-term use. However, long-term safety data in humans remains limited, and caution is warranted at high doses or when combined with certain medications.

Quercetin is generally considered safe at commonly studied doses (up to ~1000 mg/day) in short-to-medium term use; a dedicated safety review indicates a favorable profile at these levels, though very high doses or prolonged use have not been thoroughly characterized in humans. At high doses, mild gastrointestinal discomfort has been reported.

Who should avoid it

Individuals on anticoagulant therapy, immunosuppressants, or drugs with narrow therapeutic windows should consult a physician before use due to potential CYP enzyme interactions. Pregnant or breastfeeding individuals should exercise caution given insufficient safety data in these populations. Those with kidney disease should use caution, as high-dose quercetin metabolites may place additional renal burden.

Known interactions

  • ·May interact with anticoagulant/antiplatelet drugs (e.g., warfarin) by affecting platelet aggregation and drug metabolism
  • ·May inhibit CYP3A4 and CYP2C8 enzymes, potentially altering the metabolism of certain medications including some statins and chemotherapy agents
  • ·May potentiate the effects of antihypertensive medications given modest blood-pressure-lowering effects identified in meta-analysis
  • ·May interact with antibiotics, particularly fluoroquinolones, by chelating metal ions or altering gut microbiota

Pregnancy & breastfeeding

Our sources specifically flag pregnancy or breastfeeding considerations for Quercetin — see the cautions above.

We don’t assign pregnancy-safety ratings. Many supplements lack adequate safety data in pregnancy and breastfeeding, and the absence of a warning here does not mean a supplement is safe to take. Don’t start, stop, or continue any supplement while pregnant or nursing without your OB-GYN or midwife.

Read: Supplements during pregnancy & breastfeeding →

This is educational information only. Consult a healthcare provider before starting any supplement.

Stay on top of Quercetin research

One email a month when new research on Quercetin is published.

Double opt-in · unsubscribe anytime · not medical advice.

No buy link — yet

We only link products that meet our sourcing standards. We haven’t linked one for Quercetin yet. Our standards →

Key findings

  • ·Quercetin is a well-characterized flavonoid polyphenol found in many common plant-based foods and has been studied for decades for its antioxidant and anti-inflammatory properties.
  • ·A meta-analysis suggests quercetin supplementation may have a modest effect on reducing blood pressure, though the magnitude and clinical significance remain unclear.
  • ·Bioavailability of quercetin varies substantially depending on the supplement form used, as highlighted by a systematic review and meta-analysis on human intervention studies.

Evidence gaps

  • ·The vast majority of claims about quercetin's therapeutic benefits lack sufficient human clinical trial evidence — most support comes from in vitro, animal, or low-quality human studies.
  • ·Optimal supplemental dosing, timing, and formulation for specific health outcomes have not been established in well-designed, large-scale human trials.
  • ·Long-term effects and safety of quercetin supplementation at doses commonly used in supplements have not been thoroughly evaluated in human populations.